This study enrolls patients with cancer diagnoses who are expected to be hospitalized (inpatient) for at least 21 days. The purpose of this study is to determine whether a 21 day individualized massage therapy intervention, when compared to a control group, is associated with improved sleep and more robust circadian rhythms.

This study involves taking a study drug called selpercatinib. The overall goal of this study is to find out how effective the study drug is in combination with radioactive iodine (I-131) in treating people with thyroid cancer. The study drug will be given in combination with treatments you will receive as part of your regular cancer care (I-131 and thyrotropin alfa).